13don MSN
Metabolically active visceral fat linked to aggressive endometrial cancer, new study reveals
High metabolic activity of visceral fat may be associated with more aggressive endometrial cancer, new research presented at ...
A study finds that robotic-assisted surgery using 'da Vinci' technology reduces complications, shortens recovery, and ...
Research Progress and Prospects on Biomarkers for Endometrial Cancer and New Targets for Precision Diagnosis and Treatment ...
For many young adults, their late 20s are a time to dream about careers, families, and the future. But for Casey, those years were defined by something very different: a fight for her life. At 28, she ...
Sponsored by GSK. Sherry is a patient with endometrial cancer who will be discussing her experience; individual experiences may vary. Sherry has been compensated by GSK for her participation in this ...
News-Medical.Net on MSN
Visceral fat activity linked to advanced endometrial cancer
High metabolic activity of visceral fat may be associated with more aggressive endometrial cancer, new research presented today at the 38th Annual Congress of the European Association of Nuclear ...
FRESNO, Calif. (KFSN) -- Gynecological cancers affect the pelvic area in women and can harm the reproductive organs, such as the cervix and ovaries. But the most common type of gynecological cancer is ...
Talking With Docs on MSN
The overlooked truths about endometrial cancer
Dolly Parton breaks silence on health after sister calls for prayers US updates travel warnings for two countries—'Keep a low ...
In the PORTEC-3 trial, adjuvant chemoradiotherapy improved 10-year overall and recurrence-free survival in patients with high-risk endometrial cancer — particularly those with p53 abnormal tumors.
ALBUQUERQUE, N.M. — A professor at the University of New Mexico Comprehensive Cancer Center has been awarded a 5-year, $12.9 million grant to study endometrial cancer. Dr. Kimberly Leslie is set to ...
The potential benefits of GLP-1 medications continue to expand. New research has found that the weight loss and diabetes drugs — officially known as glucagon-like peptide 1 receptor agonists — are ...
AUSTIN, Texas, September 29, 2025--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of a new study in the Journal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results